銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Ambalal Sarabhai Enterprises
AMBALALSA ?NSE

Ambalal Sarabhai Enterprises

?31.94-0.21 (0.65%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
31.50
Today’s high
32.69
52 week low
30.30
52 week high
38.50
Open price
32.69
Previous close
32.15
Live volume
1,10,381
Lower circuit
25.56
Upper circuit
38.32

Fundamentals

Market Cap
?245Cr
ROE
11.24%
P/E Ratio(TTM)
13.81
EPS(TTM)
2.32
P/B Ratio
1.55
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
20.66
Debt to Equity
0.36
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?68.10
+24.77%
Profit (Cr)
?6.50
+78.57%
-200255075
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+2%
3Y CAGR-5%
Profit growthValue
1Y (TTM)+2,507%
3Y CAGR-53%

About

Ambalal Sarabhai Enterprises Limited is a diversified company with core operations in the pharmaceuticals and electronics manufacturing sectors, supported by its subsidiaries and joint ventures. Its focused subsidiaries have recorded significant progress in key areas including Active Pharmaceutical Ingredients manufacturing, Molecular Diagnostics, and niche Effervescent products. The group maintains a clear emphasis on disease-based solutions, leveraging its robust technological capabilities to drive future growth in both healthcare and electronics. Its joint venture, Vovantis, operates a USFDA-approved manufacturing plant in Ranoli, with an increased focus on products for the USA and European markets. Another key subsidiary, Synbiotics, is a USFDA inspected company that manufactures an antifungal active ingredient, Amphotericin B, for an expanding global market. Furthermore, its Asence subsidiary specializes in supplying quality pharmaceutical preparations to international markets, with over 100 products registered worldwide.;
CEO/MD
Mr. Mohal K. Sarabhai
Founded in
1977
NSE symbol
AMBALALSA

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
68.64%
Promoters
31.36%
Other Domestic Institutions
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,433.50
-95.50 (1.12%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,533.70
    -5.60 (0.12%)
    L
      H
      20,766.7328.744.94
      ?1,448.40
      +17.80 (1.24%)
      L
        H
        19,822.7430.615.08
        ?786.90
        +4.80 (0.61%)
        L
          H
          19,386.3932.583.81
          2026
          21
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com